AstraZeneca has agreed to provide 60 million vaccine doses by the end of the third quarter of 2021, 75 million by the end of the fourth quarter of 2021, and 65 million by the end of the first quarter of 2022 under the terms of the agreement.
Articles published in “Health”
Health news stories from across Metropolitan France including the latest developments in medicines, vaccines, treatments and scientific advances.
